Navigation Links
Clinical Trial Investigates Multicolor Tattoo Removal in Fewer Treatments
Date:9/15/2018

The first ever production picosecond-domain laser with a 785?nm wavelength was recently developed to improve the rate of clearance of green, blue, and purple tattoo inks - often the colors most resistant to laser removal.

A clinical trial published in Lasers in Surgery and Medicine (LSM), the official journal of the American Society for Laser Medicine and Surgery, Inc. (ASLMS) investigated the safety and efficacy of the new 785 nm Ti-Sapphire laser for treating blue, green and purple tattoo inks as an addition to a picosecond-domain 1,064 nm and 532 nm laser platform. This first study of a new, 785 nm, picosecond-domain, laser-pumped-laser demonstrates safe and effective removal of multicolor tattoos.

The study, conducted by Eric F. Bernstein, MD; Jayant Bhawalkar, PhD; and Kevin T. Schomacker, PhD, titled “A Novel Titanium Sapphire Picosecond-domain Laser Safely and Effectively Removes Purple, Blue and Green Tattoo Inks,” was selected as Editor’s Choice in the September 2018 issue of LSM.

“The laser-pumped-laser concept enables delivery of multiple discrete wavelengths from a single laser platform. A commercial 785 nm Ti-Sapphire laser has been a long time coming,” said Dr. Bernstein. “Having a picosecond-domain version for treating blue, green and purple tattoos is a big advantage.”

Eric F. Bernstein, MD, MSE received his BS from Duke University, and his MD from the Yale University School of Medicine, and an MSE in Management of Technology from the Engineering School at University of Pennsylvania, co-administered by the Wharton School. Following fellowships with the NCI at the NIH and Hahnemann University, he joined Jefferson Medical College, where he directed a photobiology laboratory and served as director of the Laser Surgery Center. Dr. Bernstein holds numerous and international patents, has authored over 100 scientific publications, and has given more than 300 presentations worldwide.

Dr. Bernstein currently directs Main Line Center for Laser Surgery, an aesthetic laser practice in Ardmore, Pennsylvania, and serves as a president of the ASLMS, the premier, global society focusing on the use of energy-based devices in medicine. Dr. Bernstein’s practice focuses heavily on studies of new lasers for FDA-clearance, and he actively participates in several start-ups.

Editor’s Choice is an exclusive article published in LSM, the official journal of the ASLMS. View the complete manuscript.

Read the full story at https://www.prweb.com/releases/clinical_trial_investigates_multicolor_tattoo_removal_in_fewer_treatments/prweb15756726.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
2. Clinical Tests Demonstrate Long-Term Effectiveness of Oral Glutathione Supplements - Kyowa Study
3. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
4. Center for Clinical and Translational Science awards new pilot grants
5. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
6. Inflection Biosciences licenses preclinical oncology programs from the CNIO
7. New sickle cell anemia therapy advances to Phase II clinical trials
8. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
9. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
10. With early, obvious benefit of a targeted cancer drug, should expensive clinical testing continue?
11. DO-HEALTH a multi-center clinical trial on healthy ageing achieves first milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/4/2019)... ... , ... Most preclinical EEG visualization platforms offer tools intended ... on variations of amplitude, frequency or spike train detection. In the clinic, however, ... complexity and variability of the signal, and automation tools are used only in ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... testing company, and Mayo Clinic, have documented significant differences in the prevalence of ... and ethnic populations compared to non-Hispanic White women. Results will be presented at ...
(Date:5/24/2019)... THE WOODLANDS, Texas (PRWEB) , ... May 24, 2019 , ... ... has been published and is now available on the company’s global website. , Crystallography ... focusing on single crystal X-ray diffraction. It serves the X-ray analysis community by presenting ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... (PRWEB) , ... April 30, ... ... the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA Inc. has ... customer requirements. In addition, REPROCELL USA Inc. aims to enhance customer satisfaction ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers ... present results documenting discrepancies between U.S. insurer policies for genetic testing and the ... for hereditary breast and ovarian cancer (HBOC). , Jill S. Dolinsky, ...
(Date:4/25/2019)... SAN FRANCISCO (PRWEB) , ... April 24, 2019 ... ... Intelligent Virtual Agents for sales and service organizations, today announced global ... contact center software providers and enterprises of all sizes to harness the power ...
(Date:4/16/2019)... ... 16, 2019 , ... Fulcrum Biometrics , a leading ... South Pacific (BSP), the largest regionally owned bank in the South Pacific, selected ... to deliver a fingerprint-based Know Your Customer (KYC) banking solution that is being ...
Breaking Biology Technology: